Nu Skin (NUS) outlines 2026 votes, 2025 results and CEO pay in proxy
Nu Skin Enterprises (NUS) released its definitive proxy statement outlining proposals for its May 28, 2026 annual meeting, including the election of nine directors, an advisory vote on executive compensation, approval of an amended incentive plan, and auditor ratification. The company detailed its 2025 financial performance, reporting $1.49 billion in revenue and showcasing its performance-based executive pay structure, which resulted in reduced cash incentives due to financial metrics falling below target levels. CEO Ryan Napierski's 2025 compensation totaled $5.97 million, predominantly equity-based, and the company emphasized strong corporate governance practices and sustainability initiatives.
Nu Skin (NUS) CFO Chelsea Lantz discloses 42,100-share Class A stake
Nu Skin Enterprises' Chief Financial Officer, Chelsea K. Lantz, has filed an initial Form 3, disclosing her beneficial ownership of 42,100 shares of Class A Common Stock. This filing establishes her equity position as an executive officer. The Form 3 is an initial statement and does not represent a buy or sell transaction.
Nu Skin (NYSE: NUS) adds $175M term loan and $75M revolver
Nu Skin Enterprises (NYSE: NUS) has secured a new Second Amended and Restated Credit Agreement on March 27, 2026, establishing a $175 million term loan and a $75 million revolving credit facility, both with five-year terms. The term loan was fully drawn at closing to refinance its prior bank debt, effectively reshaping its financing structure without adding new net debt. The new agreement includes financial covenants such as a maximum consolidated leverage ratio of 2.25 to 1.00 and a minimum interest coverage ratio of 3.00 to 1.00.
Vanguard disaggregates holdings; reports 0 shares of Nu Skin (NYSE: NUS)
The Vanguard Group has reported holding 0 shares (0%) of Nu Skin Enterprises Inc. (NYSE: NUS) common stock following an internal realignment on January 12, 2026. This change is due to certain Vanguard subsidiaries now reporting their beneficial ownership separately, as permitted by SEC Release No. 34-39538. The Schedule 13G/A filing, signed by Ashley Grim, Head of Global Fund Administration, indicates that Vanguard is no longer deemed to beneficially own securities held by these disaggregated subsidiaries.
CFO change at Nu Skin (NYSE: NUS) as Chelsea Lantz steps in
Nu Skin Enterprises announced that its EVP and CFO, James D. Thomas, resigned on March 17, 2026. The company's board has appointed Chelsea K. Lantz, Vice President and Corporate Controller, as interim CFO, effective March 18, 2026, while a search for a permanent replacement is underway. Lantz, who has been with Nu Skin since 2011, will receive an annual salary of $300,000, a 35% target incentive bonus, and a $25,000 quarterly stipend in her interim role.
NU SKIN ENTERPRISES, INC.
This article announces that Nu Skin Enterprises Inc. filed a Form 8K for March 20. The filing was published on March 20, 2026, at 04:20 PM. The text also displays current trading data for NUS stock and various market indices.
Portolan Capital Management LLC Purchases Shares of 596,724 Nu Skin Enterprises, Inc. $NUS
Portolan Capital Management LLC has acquired 596,724 shares of Nu Skin Enterprises (NYSE:NUS) with a value of approximately $7.27 million, representing a 1.21% ownership stake. This move is part of broader institutional interest in Nu Skin, with other firms like Prudential and American Century also increasing their holdings. Despite these investments, Nu Skin recently missed EPS and revenue estimates and has received mixed to negative analyst ratings.
NU SKIN (NUS) CEO Ryan Napierski receives 282,353-share equity grant
NU SKIN ENTERPRISES, INC. President and CEO Ryan S. Napierski was granted 282,353 shares of Class A Common Stock on March 6, 2026, increasing his direct holdings to 1,001,905 shares. The shares were acquired at $0.00 per share as an award, indicated by a transaction code "A" on the SEC Form 4 filing. This filing does not report any sales or disposals by the CEO.
Nu Skin (NUS) Chief Product Officer granted 77,941 Class A shares in Form 4
Nu Skin Enterprises' Chief Product Officer, Steven Keith Hatchett, was granted 77,941 shares of Class A common stock on March 6, 2026, as reported in a Form 4 SEC filing. This non-cash award at $0.00 per share increased Hatchett's direct ownership to 260,818 shares. The transaction code "A" confirms it was a grant or award acquisition, not a stock purchase.
Nu Skin (NYSE: NUS) EVP granted 138,971 Class A common shares
Nu Skin Enterprises EVP, COO, and CLO Chayce David Clark was granted 138,971 Class A Common Stock shares on March 6, 2026, increasing his direct ownership to 390,746 shares. This transaction, revealed in an SEC Form 4 filing, was a company-issued equity award rather than a market purchase. The grant highlights an increase in his beneficial ownership with no acquisition cost.
Nu Skin (NUS) EVP Justin Keisel receives 47,059-share equity grant
Justin S. Keisel, EVP and President of Global Sales at Nu Skin Enterprises, Inc. (NUS), received an equity grant of 47,059 shares of Class A Common Stock. This grant was awarded at $0.00 per share, indicating it was an equity grant rather than a market purchase. Following this transaction, Keisel directly holds 160,170 shares of Nu Skin Class A Common Stock.
NU SKIN (NUS) CFO receives 114,706-share Class A stock grant
NU SKIN (NUS) Chief Financial Officer Thomas James D was granted 114,706 shares of Class A Common Stock on March 6, 2026, at a price of $0.00 per share. This stock grant increased his directly held Class A Common Stock position to 267,102 shares. The transaction was an equity award, not an open-market purchase, and is coded as a grant, award, or other acquisition on the SEC Form 4 filing.
Segall Bryant & Hamill LLC Has $809,000 Stock Position in Nu Skin Enterprises, Inc. $NUS
Segall Bryant & Hamill LLC significantly reduced its stake in Nu Skin Enterprises (NYSE:NUS) by 66.5% during the third quarter, now holding shares worth $809,000. Despite this, institutional investors collectively own 82.84% of the company. Recent analyst downgrades and a slight miss on quarterly earnings have led to an average "Reduce" rating for Nu Skin.
Nu Skin (NUS) CEO has 124,802 shares withheld to cover taxes
Nu Skin Enterprises CEO Ryan S. Napierski had 124,802 Class A common shares withheld at a price of $8.63 per share to cover tax obligations related to the vesting of previously granted restricted stock units. This transaction, indicated by an "F" code in the SEC Form 4 filing, is a common administrative procedure and not an open-market sale. After this tax-withholding disposition, Napierski directly holds 719,552 Nu Skin Class A common shares.
Nu Skin (NUS) EVP Clark has 45,502 shares withheld for RSU taxes
Nu Skin Enterprises EVP and General Counsel Chayce David Clark reported that 45,502 shares of Class A common stock were withheld to cover tax obligations related to the vesting of restricted stock units. The shares were withheld at $8.63 each in a non-open-market transaction. Following this, Clark directly holds 251,775 shares of Nu Skin Enterprises Class A common stock.
Nu Skin (NUS) CFO has shares withheld to cover RSU tax obligations
Nu Skin Enterprises' CFO, Thomas James, reported a Form 4 transaction where 28,602 shares of Class A Common Stock were disposed of at $8.63 per share on February 26, 2026. These shares were withheld to cover tax obligations arising from previously vested restricted stock units, not an open-market sale. After this transaction, James directly holds 152,396 shares of Nu Skin Class A Common Stock.
Nu Skin (NUS) CPO has 26,001 shares withheld for taxes
Nu Skin Enterprises' Chief Product Officer, Steven Keith Hatchett, had 26,001 shares of Class A common stock withheld on February 26, 2026, to cover tax obligations arising from the vesting of Restricted Stock Units. These shares were recorded at $8.63 per share, and following this transaction, Hatchett directly owns 182,877 shares. This transaction was not an open-market sale but a tax-related disposition.
Nu Skin (NUS) executive sees shares withheld to cover tax obligations
Nu Skin Enterprises executive Justin S. Keisel had 13,687 shares of Class A common stock withheld on February 26, 2026, to cover tax obligations. This disposition, valued at $8.63 per share, was related to the vesting of previously granted restricted stock units and
BWMX: 4Q Review: Cleaning Up in 2025 Ahead of Game Changing 2026; Reiterate Buy, $30 PT
Research Tree reiterates its Buy rating and $30 price target for Betterware de Mexico (BWMX) despite 4Q25 results slightly below expectations due to a weak Mexican consumer, inventory clearing, FX issues, and JAFRA incentive shifts. The company anticipates organic mid-single digit top-line expansion driven by a more stable Mexican consumer and significant growth from the expected 2Q close of Tupperware LatAm operations in 2026. The report slightly lowers 2026 projections but rolls out solid 2027 expansion forecasts.
BWMX: 4Q Preview: Expansion, Returns Drive EPS Growth into 2026 (and Beyond)
Betterware de Mexico is expected to report strong 2026 results, driven by the Tupperware LatAm acquisition, continued high-margin growth at JAFRA, focus on returns, a weak USD, and normalization of China trade. Analyst Eric Beder reiterates a Buy rating and a $30 price target for BWMX, despite a slight tweak down in 4Q25 margin projections. The company is set to report 4Q25 results after the close on February 26th and is poised for material expansion into Central and South America.
Nu Skin (NUS) EVP Keisel has 1,534 shares withheld to cover RSU taxes
Nu Skin Enterprises, Inc. (NUS) EVP Justin S. Keisel reported a tax-related disposition where 1,534 shares of Class A Common Stock were withheld at $8.36 per share. This action was taken to cover tax obligations arising from the vesting of restricted stock units (RSUs). Following this non-open-market transaction, Keisel directly holds 126,798 shares.
Nu Skin Acquires 3i Solutions
Nu Skin Enterprises, Inc. has acquired 3i Solutions, an ingredients company specializing in proprietary encapsulation technology for cosmetics, food, and nutritional industries. This acquisition is expected to enhance Nu Skin's product innovation and formulation performance by leveraging 3i Solutions' expertise in creating water-dispersible oil-soluble materials. The CEO of Nu Skin, Ritch Wood, stated that the acquisition will benefit their sales force and consumers through improved absorption of nutritional ingredients, innovative delivery methods, controlled release of active ingredients, and new product formats.
Nu Skin (NUS) CEO has 49,037 shares withheld for tax obligations
Nu Skin Enterprises CEO Ryan S. Napierski had 49,037 shares of Class A common stock, valued at $8.36 per share, withheld on February 15, 2026, to cover tax obligations arising from vested restricted stock units. This transaction is a common administrative procedure, not an open-market sale. After the withholding, Napierski directly held 844,354 shares of Class A common stock.
Nu Skin (NYSE: NUS) EVP withholds 17,947 shares to cover taxes
Nu Skin Enterprises EVP and General Counsel Chayce David Clark had 17,947 shares of Class A common stock withheld at $8.36 per share to cover tax obligations related to the vesting of restricted stock units. After this transaction, Clark directly owns 297,277 shares. This was a tax-withholding disposition, not an open-market sale.
Nu Skin Enterprises, Inc. (NYSE:NUS) Declares Quarterly Dividend of $0.06
Nu Skin Enterprises (NYSE:NUS) has announced a quarterly dividend of $0.06 per share, payable on March 11th to shareholders of record by February 27th. This amounts to an annualized dividend of $0.24, representing a yield of approximately 2.3%. The company's dividend is well-covered by earnings, with a payout ratio of 32% and a projected future payout ratio of 22.2%.
Nu Skin Enterprises (NYSE:NUS) Short Interest Falls in Russell 1000
The article reports that Nu Skin Enterprises (NYSE:NUS) has seen a drop in its short interest within the Russell 1000 index. It covers the movement of short interest, institutional filings, and the operating structure of the company in the consumer wellness and direct selling sector. The content also provides a brief overview of what short interest, institutional ownership filings, and a direct selling model signify.
Should You Sell Your Stake in Nu Skin Enterprises (NUS)?
Aristotle Capital Boston's Small Cap Equity Fund liquidated its position in Nu Skin Enterprises (NYSE: NUS) due to deteriorated fundamental performance and an uncertain strategic transformation outlook. Despite its strong past twelve-month performance, the company saw a significant one-month decline. The article highlights that Nu Skin is not among the 30 most popular stocks among hedge funds, suggesting that AI stocks might offer greater return potential.
Short Interest in Nu Skin Enterprises, Inc. (NYSE:NUS) Drops By 16.0%
Nu Skin Enterprises (NYSE:NUS) experienced a 16.0% decrease in short interest in January, totaling 1,758,724 shares as of January 30th. This represents about 3.7% of shares outstanding with a days-to-cover ratio of 3.0 days. The company recently missed Q4 earnings estimates, but declared a quarterly dividend of $0.06 and is largely held by institutional investors with a "Hold" consensus rating from analysts.
Performance awards lift Nu Skin (NYSE: NUS) EVP’s holdings to 128,332 shares
Nu Skin Enterprises EVP Justin S. Keisel received 37,410 Class A common shares as performance-based stock awards on February 10, 2026. These awards, granted at $0.00 per share, were tied to the company meeting specific performance criteria from 2024 and 2025 restricted stock unit grants. Following these transactions, Keisel's direct holdings in Nu Skin (NYSE: NUS) increased to 128,332 shares.
Nu Skin Enterprises, Inc. (NYSE:NUS) Q4 2025 Earnings Call Transcript
Nu Skin Enterprises, Inc. (NYSE: NUS) reported its Q4 2025 earnings, with EPS slightly missing expectations but showing a strong 51% growth year-over-year. The company is undergoing a strategic transformation, centered on the launch of Prism IO, an intelligent wellness platform, and expansion into emerging markets like India. Nu Skin anticipates returning to growth by late 2026, driven by these initiatives and continued operational efficiency improvements.
$1 EPS outlook and India launch: inside Nu Skin’s 2026 plan
Nu Skin Enterprises (NYSE: NUS) reported Q4 2025 revenue of $370.3M and adjusted EPS of $0.29, which was at the high end of their guidance despite missing Stonegate Capital's revenue estimates. The company highlighted robust gross margins, disciplined spending, and strategic expansion into India, with a full launch expected in the second half of 2026. Nu Skin projects a FY26 EPS midpoint of $1.00 as it focuses on its Prysm iO rollout and geographic growth initiatives.
Top 3 Defensive Stocks That May Rocket Higher In February
This article identifies three oversold consumer staple stocks—Nu Skin Enterprises (NUS), Coty Inc (COTY), and The Honest Company (HNST)—that may be poised for a rebound in February due to their low Relative Strength Index (RSI) values. Each company's recent financial performance and stock action are mentioned, highlighting potential buying opportunities for investors. The article is based on analysis from Benzinga Pro.
Schwab unit discloses 5.37% Nu Skin (NYSE: NUS) equity stake
Charles Schwab Investment Management Inc. has reported a 5.37% beneficial ownership stake in Nu Skin Enterprises, Inc. (NYSE: NUS) Class A common stock, totaling 2,621,785 shares. This disclosure was made via a Schedule 13G filing, indicating a passive investment where Schwab maintains sole voting and dispositive power over these shares. The investment was made in the ordinary course of business and not for the purpose of influencing or changing control of Nu Skin.
Nu Skin (NUS) EVP and General Counsel receives new performance-based share awards
Nu Skin Enterprises' EVP and General Counsel, Chayce David Clark, received performance-based stock awards. On February 10, 2026, he acquired 15,667 Class A shares and an additional 75,466 Class A shares at $0.00 per share as restricted stock units tied to performance goals became eligible for vesting. These transactions increased his direct holdings to 315,224 Class A shares.
$0.06-a-share payout: Nu Skin sets March 11 dividend for investors
Nu Skin Enterprises, Inc. (NYSE: NUS) has announced a quarterly cash dividend of $0.06 per share. This dividend will be paid on March 11, 2026, to shareholders of record as of February 27, 2026. The company, an intelligent beauty and wellness platform, operates in nearly 50 global markets.
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidance
Nu Skin Enterprises reported fourth quarter and full-year 2025 results that met revenue and earnings guidance, with over 50% growth in earnings for the full year 2025. The company is strategically focusing on the global launch of Prysm iO, an intelligent wellness device, and expanding into India to drive year-over-year revenue growth by the end of 2026. Nu Skin provided an initial outlook for Q1 and fiscal year 2026, projecting continued investment in growth initiatives.
Nu Skin Enterprises Q4 Earnings, Revenue Decline
Nu Skin Enterprises reported a decline in its Q4 earnings and revenue. The company also announced its Q4 2025 earnings call for February 12, 2026, and provided future earnings guidance for the full year 2025. Nu Skin develops and distributes beauty and wellness solutions globally across various segments.
Nu Skin Enterprises (NYSE:NUS) Share Price Passes Above 200 Day Moving Average - Here's What Happened
Nu Skin Enterprises (NYSE:NUS) saw its share price move above its 200-day moving average to $10.6120, even as analyst sentiment has shifted to "Reduce." The company reported beating quarterly EPS estimates ($0.34 vs. $0.30) but missed revenue expectations and has a market cap of approximately $517.3 million. Nu Skin also announced a quarterly dividend of $0.06 and provided FY2025 EPS guidance between $1.25 and $1.35.
Nu Skin Enterprises to Announce Fourth Quarter and Full Year 2025 Financial Results
Nu Skin Enterprises (NYSE: NUS) will release its fourth quarter and full year 2025 financial results after the market closes on Thursday, February 12, 2026. The management team will host a conference call on the same day at 5 p.m. ET to discuss the results and upcoming business initiatives. A webcast of the conference call and financial information will be available on the company’s investor relations website, with a replay available until February 26.
Nu Skin Enterprises to Announce Fourth Quarter and Full Year 2025 Financial Results
Nu Skin Enterprises Inc. (NYSE: NUS) will release its fourth quarter and full year 2025 financial results after the market closes on Thursday, February 12th. Following the release, the management team will host a conference call at 5 p.m. ET to discuss the results and upcoming business initiatives. A webcast of the call and financial information will be available on the company's investor relations page, with a replay accessible until February 26th.
BWMX: 2026 Signposts: Returns Set to Continue Upward Path; Reiterate Buy, PT
Small Cap Consumer Research LLC reiterates a Buy rating and $22.50 price target for Betterware de Mexico (BWMX), citing expected top-line growth for both the Betterware division and JAFRA Mexico in 2026, following a period of inventory reduction and return optimization in 2025. The firm believes BWMX remains a compelling investment due to anticipated expansion into new countries, strong financial discipline, continued balance sheet deleveraging, and an attractive dividend yield of approximately 7.3%.
Pacer Advisors Inc. Lowers Holdings in Nu Skin Enterprises, Inc. $NUS
Pacer Advisors Inc. significantly reduced its stake in Nu Skin Enterprises (NYSE:NUS) by 55.1% in Q3, selling 267,419 shares. Despite this, other institutional investors like Prescott Group Capital Management and Prudential Financial Inc. increased their positions, with institutional ownership now at 82.84%. Nu Skin reported Q3 EPS of $0.34, exceeding estimates, with a market capitalization of $472.7 million and a price-to-earnings ratio of 4.45.
Nu Skin (NUS) details 2024 social impact, sustainability gains | NUS Stock News
Nu Skin Enterprises, Inc. (NYSE: NUS) has released its 2024 Social Impact and Sustainability Report, highlighting significant achievements in global giving and environmental sustainability. The report showcases the Nu Skin Force for Good Foundation's work, which has facilitated over 32,000 heart surgeries for children and contributed to the donation of more than 850 million meals through its Nourish the Children initiative. Additionally, the company made strides in reducing plastic waste, utilizing recycled materials, and achieving sustainable palm oil sourcing for its products.
Nu Skin Enterprises (NYSE:NUS) Stock Price Passes Above Two Hundred Day Moving Average - Should You Sell?
Nu Skin Enterprises (NYSE:NUS) stock recently traded above its 200-day moving average of $10.09, reaching $10.68. Analysts maintain a "Hold" rating with a consensus price target of $7.00, suggesting limited upside. The company reported better-than-expected Q3 EPS of $0.34 and announced a quarterly dividend of $0.06.
Nu Skin Unveils Prysm iO™: An Evolution in Intelligent Nutritional Wellness
Nu Skin Enterprises Inc. has launched Prysm iO™, an intelligent nutritional wellness platform designed to provide personalized insights into health by tracking carotenoid levels. This AI-powered device offers a non-invasive finger-scan to measure antioxidant health in under 15 seconds, supplementing a user's diet, fitness, and lifestyle choices. The platform is supported by over 20 years of research and integrates with Nu Skin's wellness ecosystem, with availability expanding to the public throughout 2026.
With 75% ownership, Nu Skin Enterprises, Inc. (NYSE:NUS) boasts of strong institutional backing
Institutional investors own 75% of Nu Skin Enterprises, Inc. (NYSE:NUS), indicating their significant influence on the company's share price and a vote of confidence in its future. The top 16 shareholders collectively hold 51% of the business, with The Vanguard Group and BlackRock being the largest, each owning 8.6%. Insiders also hold a small but significant stake, while the general public owns 23% of the company.
Walleye Capital LLC Lowers Stock Position in Nu Skin Enterprises, Inc. $NUS
Walleye Capital LLC significantly reduced its stake in Nu Skin Enterprises, Inc. (NYSE:NUS) by 52.4% during the second quarter, selling 175,435 shares and now owning 159,478 shares. Despite this, institutional investors collectively hold approximately 82.84% of the stock. Nu Skin exceeded EPS expectations for the recent quarter, forecasting FY2025 EPS between $1.25 and $1.35, and declared a quarterly dividend of $0.06.
Segall Bryant & Hamill LLC Invests $1.58 Million in Nu Skin Enterprises, Inc. $NUS
Segall Bryant & Hamill LLC has initiated a new position in Nu Skin Enterprises (NYSE:NUS), purchasing 198,006 shares valued at approximately $1.58 million during the second quarter. This investment gives the firm a 0.40% stake in the company. Nu Skin reported beating EPS expectations but missed on revenue, and announced a quarterly dividend of $0.06 per share.
Nu Skin Enterprises, Inc. (NYSE:NUS) Stock Goes Ex-Dividend In Just Four Days
Nu Skin Enterprises (NYSE:NUS) is set to trade ex-dividend in four days, with the ex-dividend date being November 28th and payment on December 10th. The company offers a 2.4% trailing yield, paying out US$0.24 per share annually, and its dividend is well-covered by both profits (11% payout ratio) and free cash flow (22% payout ratio). Despite this, the company has seen declining earnings per share (6.4% annually over five years) and a 10-year dividend payment decrease of 16% per year.
Nu Skin Enterprises Reports Third Quarter Earnings
Nu Skin Enterprises Inc. (NYSE: NUS) announced third quarter revenue of $364.2 million and EPS of $0.34, within its guidance. The company is preparing for the limited introduction of its Prysm iO intelligent wellness platform and a pre-market opening in India in the fourth quarter, aiming to stimulate growth and expand its global presence. Nu Skin's CEO, Ryan Napierski, highlighted strong double-digit growth in Latin America and positive sequential trends in several segments, emphasizing operational efficiency and upcoming strategic initiatives.
